Strategy Update: Annexin Pharmaceuticals
June 10 2021
07:45-09:15
Livesändning på Redeye.se
Live events are available to Redeye members
Sign up for a free membership
Already a member?
Sign in
Livesändning på Redeye.se
Annexin Pharmaceuticals, a leading biotechnology company in the Annexin A5-field for treatment of various vascular diseases, gives a live update followed by a Q&A session.
CEO Anders Haegerstrand will present an update on the status of the company’s key projects and priorities. In addition, CMO/CSO Anna Frostegård will present activities and roadmap for the lead project in RVO (retinal vein occlusion) in preparation for the Phase 2 study.
The company presentation is followed by a Q&A session led by Redeye Analyst Fredrik Thor.
This event will be presented in English
NOTE
Companies and schedules may change before the event starts. Save the date to your calendar by using Add to calendar.